Publications

Search our bibliography using the filters on the right-hand side.

Displaying 101 through 150 of 277 publications.

Davis KL, Kaye JA, Iyer S. Response rate and outcomes in crizotinib treated advanced ALK-positive NSCLC patients. Poster presented at the 16th World Congress on Lung Cancer; September 6, 2015. Denver, CO.

Davis KL, Kaye JA, Iyer S. Crizotinib outcomes in ALK-positive advanced NSCLC patients with brain metastases. Presented at the 16th World Conference on Lung Cancer; September 6, 2015. Denver, CO.

Tyczynski JE, Williams S, Gregory N, Garratt M, Tchakov I, Davis KL, Kaye JA, Korsnes JS, Lewis J. Overall survival in platinum-sensitive recurrent ovarian cancer: findings from a multinational medical record review. Poster presented at the 2015 Annual Meeting of the American Society of Clinical Oncology; June 2015. Chicago, IL.

Korsnes JS, Davis KL, Ariely R, Bell C, Mitra D. Health care resource utilization and costs associated with nonfatal major adverse cardiovascular events. J Manag Care Pharm. 2015 Jun;21(6):443-50.

Tyczynski J, Williams S, Gregory N, Garratt M, Tchakov I, Davis KL, Kaye JA, Korsnes J, Lewis J. Real-world treatment patterns for platinum-sensitive recurrent serous ovarian cancer: findings from a multinational medical record review. Poster presented at the 2015 American Society of Clinical Oncology Annual Meeting; June 2015. Chicago, IL. [abstract] J Clin Oncol. 2015 Jun; 33(Suppl):e16548. doi: 10.1200/jco.2015.33.15_suppl.e16548

Davis KL, Lin HM, Zhang S, Kaye JA. Current treatment patterns and survival in relapsed or refractory multiple myeloma: findings from a brief survey of European physicians. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Goyal RK, Davis KL. Short- and long-term survival associated with laparoscopic versus open colectomy in early-stage colon cancer: findings from a retrospective cohort study. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A194.

Kurosky SK, Davis KL, Krishnarajah G. Effect of receiving combination vaccines on vaccine completion and compliance rates among children aged 24 months in the United States. Presented at the National Foundation for Infectious Disease Annual Meeting; April 13, 2015. Bethesda, MD.

Wang T, Meyers J, Davis K, Madhwani S, Boklage S. Patterns of H. pylori treatment and testing for patients in a commercially insured population. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 1, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 2015 Apr; 21(4-a):S11.

Davis KL, Goyal RK, Able SL, Brown J, Li L, Kaye JA. Real-world treatment patterns, survival, and costs in a US Medicare population with metastatic squamous non–small cell lung cancer. Poster presented at the National Comprehensive Cancer Network (NCCN) 2015 Annual Conference; March 12, 2015. Hollywood, FL.

Davis KL, Goyal RK, Able SL, Brown J, Li L, Kaye JA. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer. Lung Cancer. 2015 Feb;87(2):176-85. doi: 10.1016/j.lungcan.2014.11.002

Davis KL, Gutierrez B, Zyczynski T, Kaye JA. Real-world treatment patterns in men with castration-resistant prostate cancer receiving docetaxel. JHEOR. 2015 Jan 6;2(2):119-30. doi: 10.36469/9894

Davis KL, Cote I, Kaye JA, Gao H, Perez Ronco J, Seifeldin R, Mendelson E. Real-world assessment of clinical outcomes in lower-risk myelofibrosis patients receiving treatment with ruxolitinib. Poster presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition; December 6, 2014. San Francisco, CA. [abstract] Blood. 2014 Dec 6; 124(21):1857. doi: 10.1182/blood.V124.21.1857.1857

Goyal R, Davis KL, Cote I, Mounedji N, Kaye JA. Increased incidence of thromboembolic event rates in patients diagnosed with polycythemia vera: results from an observational cohort study. Poster presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition; December 6, 2014. San Francisco, CA. [abstract] Blood. 2014 Dec 6; 124(21):4840. doi: 10.1182/blood.V124.21.4840.4840

Karve SJ, Price GL, Davis KL, Pohl GM, Smyth E, Bowman L. Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers. BMC Health Serv Res. 2014 Nov 13;14(1):555. doi: 10.1186/s12913-014-0555-8

Graham CN, Davis KL, Goyal RK. Effect of sample size and data maturity on parametric survival modeling projections in advanced cancer. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam.

Davis KL, Wei W, Meyers JL, Kilpatrick BS, Pandya N. Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study. Clin Interv Aging. 2014 Oct 23;2014(9):1815-22. doi: 10.2147/CIA.S65411

Davis KL, Wei W, Meyers JL, Kilpatrick BS, Pandya N. Association between different hemoglobin a1c levels and clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus. J Am Med Dir Assoc. 2014 Oct;15(10):757-962. doi: 10.1016/j.jamda.2014.06.007

Loftus EV, Davis KL, Wang CC, Dastani H, Luo A. Treatment patterns, complications, and disease relapse in a real-world population of patients with moderate-to-severe ulcerative colitis initiating immunomodulator therapy. Inflamm Bowel Dis. 2014 Aug;20(8):1361-7. doi: 10.1097/MIB.0000000000000089

Goyal RK, Able SL, Davis KL, Brown J, Li L, Kaye JA. Real-world treatment patterns for advanced squamous non-small cell lung cancer in the U.S. Medicare population. Poster presented at the 2014 ASCO Annual Meeting; May 2014. Chicago, IL. [abstract] J Clin Oncol. 2014 Jun 11; 32(suppl):e17652.

Davis KL, Kurosky SK. Recent trends in incidence of infant pertussis hospitalization in the United States. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.

Davis KL, Kurosky SK. Recent trends in costs, length of stay, and mortality associated with infant pertussis hospitalization in the United States. Presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.

Kurosky SK, Davis KL, Karve SJ. Tetanus toxoid, reduced diphtheria toxoid, and acellular puertussis (TDAP) vaccine compliance among adolescents in the United States, 2010-2012. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.

Blonde L, Brunton S, Chava B, Zhou R, Davis KL, Meyers JL, Dalal M, Digenio A. Achievement of goal A1C (less than 7%) by US patients with T2DM on basal insulin in both randomized controlled trials (RCTS) and in clinical practice. Poster presented at the American Diabetes Association; June 2014. San Francisco, CA.

Ariely R, Korsnes JS, Mitra D, Davis KL, Bell C. Major adverse cardiovascular events in U.S. acute coronary syndrome patients in the United States. Poster presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions; June 2014.

Rubin DT, Mody R, Davis KL, Wang CC. Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease. Aliment Pharmacol Ther. 2014 May;39(10):1143-55. doi: 10.1111/apt.12727

Davis KL, Mody R, Patel H, Rubin DT. Association between Inadequate Response to Initial Treatment with Biologics and Health Care Costs in Patients with Inflammatory Bowel Disease. Poster presented at the 2014 AMCP 26th Annual Meeting & Expo; April 2014.

Price GL, Davis KL, Karve S, Pohl G, Walgren RA. Survival patterns in United States (US) Medicare enrollees with non-CML myeloproliferative neoplasms (MPN). PLoS One. 2014 Mar 11;9(3):e90299. doi: 10.1371/journal.pone.0090299

Pandya N, Wei W, Meyers J, Kilpatrick B, Davis K. Burden of sliding scale insulin use in elderly long-term care residents with type 2 diabetes mellitus. J Am Geriatr Soc. 2013 Dec;61(12):2103-10. doi: 10.1111/jgs.12547.

Davis KL, Candrilli S. Recent trends in hospital costs, length of stay, and mortality associated with pediatric meningococcal disease in the United States. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. [abstract] Value Health. 2013 Nov; 16(7):A349.

Davis KL, Candrilli S. Recent trends in incidence and demographics of pediatric meningococcal disease in the United States. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. [abstract] Value Health. 2013 Nov; 16(7):A342.

Davis KL, Tangirala M, Meyers JL, Wei W. Real-World Comparative Outcomes of US Type 2 Diabetes Patients Initiating Analog Basal Insulin Therapy. Curr Med Res Opin. 2013 Aug 1;29(9):1083-91.

Cohen CJ, Meyers JL, Davis KL. Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV. BMJ Open. 2013 Aug 1;3(8):e003028.

Meyers J, Yu Y, Kaye JA, Davis KL. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy. 2013 May 16;11(3):275-86. doi: 10.1007/s40258-013-0032-2

Davis KL, Fitzgerald TP, Meyers J, Kulkarni A, Svarvar P, Hewitt DJ. Economic burden of adverse treatment effects in parkinson's disease: evidence from a large employer population. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A103-4.

Davis KL, Fitzgerald T, Meyers J, Kulkarni A, Svarvar P, Hewitt D. Incidence of adverse treatment effects in parkinson's disease: evidence from a large employer population. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 15, 2013. [abstract] Value Health. 2013 May; 16(3):A100.

Davis KL, Fitzgerald T, Kulkarni A, Meyers J, Svarvar P, Hewitt D. Comparative risk of adverse treatment effects in parkinson's disease: evidence from a large employer population. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 15, 2013. [abstract] Value Health. 2013 May; 16(3):A100.

Davis KL, Wang E, Dastani H, Luo A, Loftus EV. Treatment patterns, complications, and disease relapse in a real-world population of moderate-to-severe ulcerative colitis patients initiating immunosuppressive therapy. Poster presented at the 2013 Digestive Disease Week; May 2013.

Davis KL, Mody R, Rubin DT, Wang E. Association between suboptimal therapy and health care costs in inflammatory bowel disease. Poster presented at the 2013 Digestive Disease Week; May 2013.

Zhao Z, McCollam PL, Davis KL, Meyers JL, Murakami M. Statin adherence and persistence among Japanese patients with high risk vascular disease: a Japan claims database analysis. Poster presented at the American Heart Association Quality of Care and Outcomes Research Meeting; May 2013.

Davis KL, Meyers J, Zhao Z, McCollam P, Murakami M. High-risk vascular disease in Japan: evidence on incidence and prevalence, patient characteristics, and treatment rates from a large Japanese claims database. Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 23, 2013. [abstract] Value Health. 2013 Apr; 16(3):A277.

Karve S, Misurski DA, Meier G, Davis KL. Employer-incurred health care costs and productivity losses associated with influenza. Hum Vaccin Immunother. 2013 Apr 1;9(4):841-57.

Karve S, Misurski D, Herrera-Taracena G, Davis KL. Annual all-cause healthcare costs among influenza patients with and without influenza-related complications: analysis of a United States managed care database. Appl Health Econ Health Policy. 2013 Apr 1;11(2):119-28.

Hodgkins P, Setyawan J, Mitra D, Davis K, Quintero J, Fridman M, Shaw M, Harpin V. Management of adhd in children across europe: patient demographics, physician characteristics and treatment patterns. Eur J Pediatr. 2013 Feb 1;172(7):895-906.

Karve S, Meier G, Davis KL, Misurski DA, Wang CC. Influenza-related health care utilization and productivity losses during seasons with and without a match between the seasonal and vaccine virus B lineage. Vaccine. 2013;31(33):3370-88.

Davis KL, Price GL, Karve SJ, Pohl G, Walgren RA. Comorbidity burden in elderly persons with non-cml myeloproliferative neoplasms: real-world evidence from a United States Medicare population. Poster presented at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition; December 2012. Atlanta, GA. [abstract] Blood. 2012 Nov 16; 120(21):1734. doi: 10.1182/blood.V120.21.1734.1734

Karve SJ, Price GL, Davis KL, Pohl G, Walgren RA. Health care utilization and associated costs in elderly persons with myeloproliferative neoplasms: real-world evidence from a United States Medicare population. Poster presented at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition; December 2012. Atlanta, GA. [abstract] Blood. 2012 Nov 16; 120(21):4273. doi: 10.1182/blood.V120.21.4273.4273

Price GL, Davis KL, Karve SJ, Pohl G, Walgren RA. Survival patterns in elderly patients with myeloproliferative neoplasms: real-world evidence from a United States Medicare population. Poster presented at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition; December 2012. Atlanta, GA. [abstract] Blood. 2012 Nov 16; 120(21):428. doi: 10.1182/blood.V120.21.428.428

Candrilli S, Davis KL, Yen L. Characteristics of diverticulitis-related emergency department visits in the United States. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A328.

Davis KL, Mitra D, Yen L. Clinical characteristics, treatment patterns, and resource utilization in a real-world European population with diverticulitis. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A535-6.